CHICAGO – New advances against melanoma, ovarian cancer, and colorectal cancer care were presented today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)…. read more.
New research analysing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published… read more.
by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.
by Bruce Sylvester – European Organisation for the Research and Treatment of Cancer (EORTC) researchers from the AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial reported… read more.
by Bruce Sylvester – More than half of patients with metastatic melanoma treated with the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab have achieved durable tumor… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study.
Greater sensitivity, with lower radiation dose, allows for faster treatment, reported at 93rd AATS Annual Meeting. Lung cancer is associated with very high mortality, in part because it… read more.
FDA Highlights by Bruce Sylvester – Patients suffering chemotherapy-induced peripheral neuropathy treated with the anti-depressant duloxetine for 5 weeks achieved a greater reduction in pain compared with patients… read more.
Effects reduced by up to 30 percent by low-vitamin D season. For women diagnosed with oestrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in… read more.
Taken from The Lancet – by Bruce Sylvester – Short-term folic acid supplement use does not affect overall cancer risk and does little to increase the risk of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
